Influence of febuxostat and Topiroxostat on renal function

Influence of febuxostat and Topiroxostat on renal function - Influence of febuxostat and Topiroxostat on renal function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014771

Enrollment

Registered

2014-09-01

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperuricemia

Interventions

Febuxostat group Topiroxostat group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who is taking Allopurinol or febuxostatfor hyperuricemia 2) Patients from whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients from whom informed consent was not obtained

Design outcomes

Primary

Measure	Time frame
1) Serum uric acid 2) Urinary Albumin	—

Secondary

Measure	Time frame
1) serum Cr 2) eGFR 3) cystatin C 4) Oxidized LDL 5) T-cho, TG, LDL,HDL 6)PWV 7)BNP, EF, LVM 8) side effects	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Nihon University School of Medicine Department of Cardiovascular Surgery

asezai.med@gmail.com03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026